tiprankstipranks
Advertisement
Advertisement

CVAC Stock Latest News

CureVac’s CVGBM Brain Cancer Vaccine Trial Reaches Completion: What It Means for CVAC Investors
Company AnnouncementsCureVac’s CVGBM Brain Cancer Vaccine Trial Reaches Completion: What It Means for CVAC Investors
5M ago
CVAC
Four new option listings and one option delisting on January 7th
PremiumThe Fly
Four new option listings and one option delisting on January 7th
7M ago
SMX
CVAC
CureVac Completes BioNTech-Driven Reorganization and Moves to Delist from Nasdaq
PremiumCompany Announcements
CureVac Completes BioNTech-Driven Reorganization and Moves to Delist from Nasdaq
7M ago
6K
CVAC
BioNTech achieves minimum condition in CureVac exchange offer
PremiumThe Fly
BioNTech achieves minimum condition in CureVac exchange offer
8M ago
BNTX
CVAC
CureVac Shareholders Approve BioNTech Exchange Offer
PremiumCompany Announcements
CureVac Shareholders Approve BioNTech Exchange Offer
8M ago
6K
CVAC
BioNTech shares update on exchange offer for CureVac shares
PremiumThe FlyBioNTech shares update on exchange offer for CureVac shares
8M ago
BNTX
CVAC
CureVac Reports Q3 2025 Financial Results and Updates
Premium
Company Announcements
CureVac Reports Q3 2025 Financial Results and Updates
8M ago
CVAC
Midday Fly By: Novo Alzheimer’s trial misses goal, Green Dot to be acquired
Premium
The Fly
Midday Fly By: Novo Alzheimer’s trial misses goal, Green Dot to be acquired
8M ago
JD
QS
CureVac Reports Q3 2025 Financials and BioNTech Transaction Progress
PremiumCompany Announcements
CureVac Reports Q3 2025 Financials and BioNTech Transaction Progress
8M ago
6K
CVAC
CureVac reports Q3 revenue EUR 54.1M vs. EUR 493.9M last year
PremiumThe Fly
CureVac reports Q3 revenue EUR 54.1M vs. EUR 493.9M last year
8M ago
CVAC
CureVac reports Q3 EPS EUR 1.21 vs. EUR 1.51 last year
PremiumThe Fly
CureVac reports Q3 EPS EUR 1.21 vs. EUR 1.51 last year
8M ago
CVAC
CureVac sees cash runway into 2028
PremiumThe Fly
CureVac sees cash runway into 2028
8M ago
CVAC
CVAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCVAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
CVAC
CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment
Premium
Company Announcements
CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment
9M ago
CVAC
CureVac Announces Extraordinary Meeting for Merger with BioNTech
Premium
Company Announcements
CureVac Announces Extraordinary Meeting for Merger with BioNTech
9M ago
6K
CVAC
BioNTech commences public exchange offer for CureVac shares
PremiumThe Fly
BioNTech commences public exchange offer for CureVac shares
9M ago
BNTX
CVAC
CureVac’s Strategic Moves and Financial Highlights in 2025
PremiumCompany Announcements
CureVac’s Strategic Moves and Financial Highlights in 2025
11M ago
CVAC
CureVac Reports Financial Losses in Mid-2025
PremiumCompany Announcements
CureVac Reports Financial Losses in Mid-2025
11M ago
6K
CVAC
CureVac reports Q2 revenue EUR 1.2M vs. EUR 14.4M last year
PremiumThe Fly
CureVac reports Q2 revenue EUR 1.2M vs. EUR 14.4M last year
11M ago
CVAC
CureVac sees cash runway into 2028
PremiumThe FlyCureVac sees cash runway into 2028
11M ago
CVAC
GSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigation
Premium
The Fly
GSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigation
12M ago
GSK
PFE
CureVac Resolves Patent Litigation with Pfizer/BioNTech
Premium
Company Announcements
CureVac Resolves Patent Litigation with Pfizer/BioNTech
12M ago
6K
CVAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >